Literature DB >> 3048758

In vivo and in vitro responses to quinine and quinidine of Plasmodium falciparum.

A Sabchareon, T Chongsuphajaisiddhi, V Sinhasivanon, P Chanthavanich, P Attanath.   

Abstract

A total of 66 Thai children with uncomplicated falciparum malaria were treated orally with regimens of either quinine or quinidine. Radical cures were observed in 85% (28 of 33) of the children who received quinine and in 88% (29 out of 33) of those who received quinidine. Treatment failures in both groups were RI responses.The mean trough level of quinidine (10 mumol/l) was about 2.5-times less than that of quinine (25 mumol/l). The electrocardiograms of the two treatment groups differed significantly in that there was an acute prolongation of the QT(c) interval in 56% of those who received quinidine compared with 21.0% of those given quinine. In vitro assays of the pretreatment drug susceptibilities of the isolates of Plasmodium falciparum indicated that the mean minimum inhibitory concentration (MIC) for quinidine (1.44 mumol/l) was about half that for quinine (3.02 mumol/l). Although both drugs are equally effective, quinine is recommended for treatment of multidrug-resistant malaria in paediatric patients, primarily because of the cardiac effects produced by quinidine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3048758      PMCID: PMC2491121     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  10 in total

1.  QUANTITATIVE DETERMINATION OF QUINIDINE IN PLASMA.

Authors:  G CRAMER; B ISAKSSON
Journal:  Scand J Clin Lab Invest       Date:  1963       Impact factor: 1.713

2.  The eosin colour test of Dill and Glazko: a simple field test to detect chloroquine in urine.

Authors:  J Lelijveld; H Kortmann
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

3.  Treatment of falciparum malaria with quinne and tetracycline or combined mefloquine/sulfadoxine/pyrimethamine on the Thai-Kampuchean border.

Authors:  S R Meek; E B Doberstyn; B A Gaüzère; C Thanapanich; E Nordlander; S Phuphaisan
Journal:  Am J Trop Med Hyg       Date:  1986-03       Impact factor: 2.345

4.  In vivo and in vitro sensitivity of Falciparum malaria to quinine in Thai children.

Authors:  T Chongsuphajaisiddhi; A Sabcharoen; P Attanath
Journal:  Ann Trop Paediatr       Date:  1981-03

5.  Treatment of quinine resistant falciparum malaria in Thai children.

Authors:  T Chongsuphajaisiddhi; A Sabchareon; P Attanath
Journal:  Southeast Asian J Trop Med Public Health       Date:  1983-09       Impact factor: 0.267

6.  In vitro response of Plasmodium falciparum in Thailand to antimalarial drugs.

Authors:  P Sucharit; P Eamsobhana
Journal:  Ann Trop Med Parasitol       Date:  1980-02

7.  Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique.

Authors:  K H Rieckmann; G H Campbell; L J Sax; J E Mrema
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

8.  Tetracyclines and permanent teeth: the relation between dose and tooth color.

Authors:  E R Grossman; A Walchek; H Freedman
Journal:  Pediatrics       Date:  1971-03       Impact factor: 7.124

9.  A phase-III clinical trial of mefloquine in children with chloroquine-resistant falciparum malaria in Thailand.

Authors:  T Chongsuphajaisiddhi; A Sabchareon; P Chantavanich; V Singhasivanon; P Attanath; W H Wernsdorfer; U K Sheth
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

10.  Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies.

Authors:  R E Phillips; D A Warrell; N J White; S Looareesuwan; J Karbwang
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245

  10 in total
  7 in total

1.  Severe falciparum malaria in nonendemic areas: an unrecognized medical emergency.

Authors:  M Chamberland; R Duperval; J A Marcoux; P Dubé; N Pigeon
Journal:  CMAJ       Date:  1991-02-15       Impact factor: 8.262

2.  A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males.

Authors:  J Karbwang; T M Davis; S Looareesuwan; P Molunto; D Bunnag; N J White
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

Review 3.  Treatment of malaria--1990.

Authors:  D M Panisko; J S Keystone
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

4.  Susceptibility of Plasmodium falciparum to different doses of quinine in vivo and to quinine and quinidine in vitro in relation to chloroquine in Liberia.

Authors:  A Björkman; M Willcox; N Marbiah; D Payne
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

Review 5.  Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria.

Authors:  Jane Achan; Ambrose O Talisuna; Annette Erhart; Adoke Yeka; James K Tibenderana; Frederick N Baliraine; Philip J Rosenthal; Umberto D'Alessandro
Journal:  Malar J       Date:  2011-05-24       Impact factor: 2.979

6.  The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review.

Authors:  Ilsa L Haeusler; Xin Hui S Chan; Philippe J Guérin; Nicholas J White
Journal:  BMC Med       Date:  2018-11-07       Impact factor: 8.775

7.  Clinical pharmacokinetics of quinine and its relationship with treatment outcomes in children, pregnant women, and elderly patients, with uncomplicated and complicated malaria: a systematic review.

Authors:  Teerachat Saeheng; Kesara Na-Bangchang
Journal:  Malar J       Date:  2022-02-10       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.